ArticleCardio-oncology (London, England)2025

Safety and efficacy of immune checkpoint inhibitors in patients with pre-treatment reduced left ventricular function.

Maor Tzuberi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.